In addition, the Keap1-Nrf2 system has recently emerged as an important therapeutic target in the treatment of a variety of diseases, including cancer, neurological disorders, autoimmune diseases, and inflammatory conditions [49]. The gene discussed is KEAP1; the disease is cancer.